Letko, Brosseau & Associates’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$66.3K	Hold	17,300	–	–	﹤0.01%	93
2025 Q1	$99.5K	Hold	17,300	–	–	﹤0.01%	85
2024 Q4	$86.3K	Buy	+17,300	New	+$86.3K	﹤0.01%	97